Raymond James & Associates Has $551,000 Stake in Trupanion, Inc. (NASDAQ:TRUP)

Raymond James & Associates lessened its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 18.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,054 shares of the financial services provider’s stock after selling 4,100 shares during the period. Raymond James & Associates’ holdings in Trupanion were worth $551,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP lifted its stake in Trupanion by 5.3% during the third quarter. Wellington Management Group LLP now owns 1,823,530 shares of the financial services provider’s stock worth $51,424,000 after purchasing an additional 91,895 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Trupanion by 5.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 292,941 shares of the financial services provider’s stock worth $8,261,000 after buying an additional 14,044 shares during the last quarter. Lagoda Investment Management L.P. boosted its stake in Trupanion by 19.3% in the third quarter. Lagoda Investment Management L.P. now owns 240,785 shares of the financial services provider’s stock valued at $6,790,000 after buying an additional 38,905 shares in the last quarter. Tudor Investment Corp Et Al acquired a new stake in Trupanion in the third quarter valued at about $4,712,000. Finally, Swiss National Bank grew its position in Trupanion by 1.5% in the third quarter. Swiss National Bank now owns 81,610 shares of the financial services provider’s stock valued at $2,301,000 after acquiring an additional 1,200 shares during the last quarter.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on TRUP. Evercore ISI lowered their price target on shares of Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a report on Tuesday, February 20th. Piper Sandler lowered their target price on Trupanion from $32.00 to $28.00 and set a “neutral” rating for the company in a report on Friday, April 5th. Finally, Stifel Nicolaus lifted their price target on Trupanion from $25.00 to $28.00 and gave the company a “hold” rating in a research note on Friday, February 16th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $33.20.

Trupanion Price Performance

Shares of NASDAQ:TRUP opened at $23.31 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. Trupanion, Inc. has a 52 week low of $18.45 and a 52 week high of $37.71. The firm has a market cap of $974.59 million, a PE ratio of -21.58 and a beta of 1.71. The firm’s fifty day moving average is $25.67 and its 200-day moving average is $26.85.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, February 15th. The financial services provider reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.13. The firm had revenue of $295.50 million for the quarter, compared to the consensus estimate of $289.84 million. Trupanion had a negative return on equity of 15.19% and a negative net margin of 4.03%. The business’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.23) EPS. Sell-side analysts predict that Trupanion, Inc. will post -0.43 earnings per share for the current year.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.